Third, other immune cells, such as CD4+, CD163+, PD-1+, and PD-L1+ TILs, were not evaluated in the present study, which could be helpful for a comprehensive understanding of the relationship between systemic inflammation and the tumor microenvironment. The gene discussed is CD4; the disease is neoplasm.